Featured on Vancouver Economic Commission: AbCellera Biologics describes unprecedented speed of innovation

“In March, Vancouver-based biotech firm AbCellera Biologics Inc.became the first company in North America to receive a blood sample from a patient who had recovered from COVID-19. Within days of using their industry-leading antibody technology to analyze the sample, the team had identified 500 antibodies with potential to treat the respiratory illness – the world’s largest panel of antibodies to date.”

Read full coverage on Vancouver Economic Commission.

PARTNERSHIP

Together we can make game-changing discoveries.